Anavex Life Sciences Corp. (AVXL) vs Precision BioSciences, Inc. (DTIL)

A side-by-side comparison of Anavex Life Sciences Corp. and Precision BioSciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AVXL vs DTIL

growth of $100 · dividends reinvested · last 8y
AVXL -46.4% (-7.5%/yr)DTIL -98.8% (-42.4%/yr)AVXL compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $100202120232025$54$1
AVXL DTIL

AVXL vs DTIL: by the numbers

  • •DTIL is the larger company ($173M vs $148M market cap).
  • •Both run net losses; AVXL's is the smaller (0.00% vs -117.04% net margin).

Metrics side by side

Valuation

MetricAVXLDTIL
P/S ratioN/A3.83
P/B ratio1.313.81

Profitability

MetricAVXLDTIL
Gross margin0.00%100.00%
Operating margin0.00%-152.19%
Net margin0.00%-117.04%
ROE-21.38%-116.42%
ROIC-27.25%-30.23%

Growth (annualized)

MetricAVXLDTIL
Revenue CAGR (5Y)N/A7.13%
Total return CAGR (5Y)-37.74%-54.84%

Frequently asked

How have AVXL and DTIL total returns compared?
Over the past 5 years, AVXL delivered -37.74% and DTIL delivered -54.84% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.